Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. [electronic resource]
Producer: 20020321Description: 427-31 p. digitalISSN:- 0161-6420
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- adverse effects
- Drug Evaluation
- Female
- Glaucoma -- drug therapy
- Humans
- Immunosuppressive Agents -- immunology
- Injections
- Intraocular Pressure
- Male
- Middle Aged
- Postoperative Complications
- Prospective Studies
- Safety
- Trabeculectomy
- Transforming Growth Factor beta -- immunology
- Transforming Growth Factor beta2
- Treatment Outcome
- Visual Acuity
- Wound Healing -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.